NXTM Share Price

Open 24.16 Change Price %
High 24.47 1 Day 0.07 0.29
Low 24.12 1 Week 0.06 0.25
Close 24.34 1 Month 1.20 5.19
Volume 155393 1 Year 1.82 8.08
52 Week High 30.80
52 Week Low 20.45
NXTM Important Levels
Resistance 2 24.66
Resistance 1 24.53
Pivot 24.31
Support 1 24.15
Support 2 24.02
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
More..
NASDAQ USA Top Gainers Stocks
SCHS 0.05 66.67%
CPWR 4.65 55.00%
LOCM 0.09 50.00%
VRTB 3500.00 33.33%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
SRPT 40.93 20.10%
AEZS 2.80 19.66%
GEVO 0.71 18.33%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
QKLS 0.11 -47.62%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

NxStage Medical, Inc. (NASDAQ: NXTM)

NXTM Technical Analysis 1.5
As on 20th Jul 2017 NXTM Share Price closed @ 24.34 and we RECOMMEND Sell for LONG-TERM with Stoploss of 25.36 & Buy for SHORT-TERM with Stoploss of 23.58 we also expect STOCK to react on Following IMPORTANT LEVELS.
NXTM Target for July
1st Target up-side 27.29
2nd Target up-side 28.85
3rd Target up-side 30.41
1st Target down-side 22.85
2nd Target down-side 21.29
3rd Target down-side 19.73
NXTM Other Details
Segment EQ
Market Capital 626582144.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.nxstage.com
NXTM Address
NXTM
350 Merrimack Street
Lawrence, MA 01843
United States
Phone: 978-687-4700
NXTM Latest News
Interactive Technical Analysis Chart NxStage Medical, Inc. ( NXTM NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on NxStage Medical, Inc.
NXTM Business Profile
NxStage Medical, Inc. (NxStage) is a medical device company that develops, manufactures and markets products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. The Company�s primary product is the NxStage System One (System One). It also sells needles and blood tubing sets primarily to dialysis clinics for the treatment of end-stage renal disease (ESRD). It operates in two segments: System One and In-Center. It distributes its products in three markets: home, critical care and in-center. In the System One segment it derives its revenues from the sale and rental of the System One and PureFlow SL equipment, and the sale of disposable products in the home and critical care markets. In the In-Center segment, it derives its revenues from the sale of blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers and needles for apheresis, which is referred to as the in-center market.